// App-Quantinova.ai

3789 : Targeting cholesterol biosynthesis pathway to inhibit growth of drug resistant ovarian cancer cells

Researchers

Presenter

  • Yayun Liang

Principal Investigators

  • Johannes Aebi

  • Kenneth Nephew

  • Salman M. Hyder

Medical Centers

  • University of Missouri-Columbia, Columbia, MO

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Indiana University, Bloomington, IN

Locations

  • United States

  • Switzerland

Companies

  • F. Hoffmann-La Roche

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gynaecological cancer

  • Ovarian cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • University of Missouri College of Veterinary Medicine

  • University of Missouri and Ellis Fischel Cancer Center

Result

  • N/A